1 0 1
D E C E M B E R 2 0 1 4 | O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E
pressure," he adds. "That's why I think the ideal solution would be to
have both systems implanted, draining to Schlemm's canal and the
suprachoroidal space."
The advances' advantages
"None of these minimally invasive glaucoma surgeries are as strong as
trabeculectomy or tube shunts, but they allow you to intervene in the
glaucoma cascade earlier," says Dr. Olander. "Glaucoma is a
marathon," and treatments that can slow its progress benefit patients.
They also stand to postpone more intensive approaches and their
attendant maintenance and risks. "Trabeculectomy is the strongest
procedure we have, but it leaves a hole in the eye. That's the last thing
you want to do," says Dr. Newsom. SLT, ECP and mini-stents can
potentially sidestep that hole. "There is a huge opportunity for addi-
tional services." OSM
E-mail
db erna rd@outpa tientsurg ery.net
.
O P H T H A L M O L O G Y
